The gut in cancer, brain and heart problems

It is my moral duty to continue to keep you informed on the dramatic effects our diet has on practically ALL organs of the body. This is mostly mediated by the micro-organisms that live in your gut. It is that simple. This blog is to continue to share the dramatic findings that are not getting to the public “for some reason.” At least read the titles…

The human microbiome and the future practice of medicine

JAMA 2-15;314:1127


Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

J Cell Volume 163, Issue 7 , p1585–1595, 17 December 2015

Trimethylamine (TMA) N-oxide (TMAO), a gut-microbiota-dependent metabolite, both enhances atherosclerosis in animal models and is associated with cardiovascular risks in clinical studies. Here, we investigate the impact of targeted inhibition of the first step in TMAO generation, commensal microbial TMA production, on diet-induced atherosclerosis. A structural analog of choline, 3,3-dimethyl-1-butanol (DMB), is shown to non-lethally inhibit TMA formation from cultured microbes, to inhibit distinct microbial TMA lyases, and to both inhibit TMA production from physiologic polymicrobial cultures (e.g., intestinal contents, human feces) and reduce TMAO levels in mice fed a high-choline or L-carnitine diet. DMB inhibited choline diet-enhanced endogenous macrophage foam cell formation and atherosclerotic lesion development in apolipoprotein e−/− mice without alterations in circulating cholesterol levels. The present studies suggest that targeting gut microbial production of TMA specifically and non-lethal microbial inhibitors in general may serve as a potential therapeutic approach for the treatment of cardiometabolic diseases.”

C:\Users\hugo\Desktop\Clinic\RECENT PICS\Microbiome heart dz.jpg

Immunotherapy Meets Microbiota

J Cell Volume 163, Issue 7 , p1561, 17 December 2015

“This issue’s Select focuses on the recent development in the understanding of how gut microbiota impact the anti-cancer efficacy of immune checkpoint blockers.”

Bifidobacterium longum may reduce stress and improve cognition

Society for Neuroscience 2015 Chicago. J, Neurology News Dec 2015 p22

Hugo Rodier, MD is an integrative physician based in Draper, Utah who specializes in healing chronic disease at the cellular level by blending proper nutrition, lifestyle changes, & allopathic practices when necessary.

Leave a Reply


captcha *

Information on this blog is provided for informational purposes only and is not intended as a substitute for the advice provided by your physician or other healthcare professional. You should not use the information on this blog for diagnosing or treating a health problem or disease, or prescribing any medication or other treatment. These statements have not been evaluated by the Food and Drug Administration. Please consult your health care practitioner with any questions or concerns you may have.